ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 219 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 1,366,547 | $48,717,401 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 31,882 | $1,136,593 | 0.24% |
| HighVista Strategies LLC | 14,591 | $520,169 | 0.24% |
| Eventide Asset Management | 359,000 | $12,798,350 | 0.23% |
| FEDERATED HERMES, INC. | 2,196,500 | $78,305,225 | 0.21% |
| Hudson Bay Capital Management LP | 1,468,544 | $52,353,594 | 0.21% |
| Corton Capital Inc. | 8,856 | $315,716 | 0.16% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 748,278 | $26,676,111 | 0.16% |
| PDT Partners, LLC | 33,229 | $1,184,614 | 0.15% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 139,870 | $4,986,366 | 0.15% |
| FRED ALGER MANAGEMENT, LLC | 638,866 | $22,775,573 | 0.13% |
| Virtus ETF Advisers LLC | 6,072 | $216,467 | 0.13% |
| Alkeon Capital Management | 1,943,815 | $69,297,005 | 0.12% |
| DUALITY ADVISERS, LP | 27,038 | $963,905 | 0.12% |
| GW&K Investment Management, LLC | 310,915 | $11,084 | 0.11% |
| PIER 88 INVESTMENT PARTNERS LLC | 11,680 | $416,392 | 0.10% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 221,246 | $7,887,420 | 0.10% |
| MOORE CAPITAL MANAGEMENT, LP | 150,000 | $5,347,500 | 0.10% |
| Crestwood Advisors Group, LLC | 100,258 | $3,574,198 | 0.09% |
| Woodline Partners LP | 205,483 | $7,325,469 | 0.09% |
External links
This page lists ULTRAGENYX PHARMACEUTICAL IN's shareholders in Q3 2023. To view ULTRAGENYX PHARMACEUTICAL IN's shareholder history, click here.